Annual Current Liabilities
$13.42 M
+$5.64 M+72.54%
December 31, 2023
Summary
- As of February 7, 2025, ABEO annual total current liabilities is $13.42 million, with the most recent change of +$5.64 million (+72.54%) on December 31, 2023.
- During the last 3 years, ABEO annual current liabilities has fallen by -$28.54 million (-68.01%).
- ABEO annual current liabilities is now -68.01% below its all-time high of $41.96 million, reached on December 31, 2020.
Performance
ABEO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$18.42 M
+$1.58 M+9.37%
September 30, 2024
Summary
- As of February 7, 2025, ABEO quarterly total current liabilities is $18.42 million, with the most recent change of +$1.58 million (+9.37%) on September 30, 2024.
- Over the past year, ABEO quarterly current liabilities has increased by +$5.00 million (+37.25%).
- ABEO quarterly current liabilities is now -56.10% below its all-time high of $41.96 million, reached on December 31, 2020.
Performance
ABEO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ABEO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.5% | +37.3% |
| 3 y3 years | -68.0% | -30.4% |
| 5 y5 years | -34.1% | -9.0% |
ABEO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.3% | +72.5% | at high | +148.3% |
| 5 y | 5-year | -68.0% | +72.5% | -56.1% | +148.3% |
| alltime | all time | -68.0% | +2978.4% | -56.1% | +2708.2% |
Abeona Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.42 M(+9.4%) |
| Jun 2024 | - | $16.84 M(+41.7%) |
| Mar 2024 | - | $11.89 M(-11.4%) |
| Dec 2023 | $13.42 M(+72.5%) | $13.42 M(+59.6%) |
| Sep 2023 | - | $8.41 M(-10.9%) |
| Jun 2023 | - | $9.44 M(+27.2%) |
| Mar 2023 | - | $7.42 M(-4.6%) |
| Dec 2022 | $7.78 M(-53.2%) | $7.78 M(-38.3%) |
| Sep 2022 | - | $12.60 M(-7.9%) |
| Jun 2022 | - | $13.69 M(+10.9%) |
| Mar 2022 | - | $12.34 M(-25.8%) |
| Dec 2021 | $16.62 M(-60.4%) | $16.62 M(-37.2%) |
| Sep 2021 | - | $26.47 M(-36.8%) |
| Jun 2021 | - | $41.87 M(+2.5%) |
| Mar 2021 | - | $40.84 M(-2.7%) |
| Dec 2020 | $41.96 M(+8.4%) | $41.96 M(+8.3%) |
| Sep 2020 | - | $38.74 M(+3.1%) |
| Jun 2020 | - | $37.56 M(+2.6%) |
| Mar 2020 | - | $36.61 M(-5.4%) |
| Dec 2019 | $38.70 M(+90.1%) | $38.70 M(+91.2%) |
| Sep 2019 | - | $20.24 M(-20.8%) |
| Jun 2019 | - | $25.54 M(+19.3%) |
| Mar 2019 | - | $21.42 M(+5.2%) |
| Dec 2018 | $20.35 M(+263.0%) | $20.35 M(+97.0%) |
| Sep 2018 | - | $10.33 M(+78.6%) |
| Jun 2018 | - | $5.78 M(-10.4%) |
| Mar 2018 | - | $6.45 M(+15.1%) |
| Dec 2017 | $5.61 M(-32.4%) | $5.61 M(+112.5%) |
| Sep 2017 | - | $2.64 M(-37.4%) |
| Jun 2017 | - | $4.22 M(-30.4%) |
| Mar 2017 | - | $6.07 M(-26.9%) |
| Dec 2016 | $8.30 M(+461.7%) | $8.30 M(+27.3%) |
| Sep 2016 | - | $6.51 M(-25.2%) |
| Jun 2016 | - | $8.71 M(+13.9%) |
| Mar 2016 | - | $7.64 M(+417.5%) |
| Dec 2015 | $1.48 M(-49.0%) | $1.48 M(-5.9%) |
| Sep 2015 | - | $1.57 M(-18.2%) |
| Jun 2015 | - | $1.92 M(+54.8%) |
| Mar 2015 | - | $1.24 M(-57.2%) |
| Dec 2014 | $2.90 M(-67.7%) | $2.90 M(-77.0%) |
| Sep 2014 | - | $12.62 M(+12.9%) |
| Jun 2014 | - | $11.17 M(+11.2%) |
| Mar 2014 | - | $10.04 M(+12.1%) |
| Dec 2013 | $8.96 M(+35.2%) | $8.96 M(+11.9%) |
| Sep 2013 | - | $8.01 M(+3.1%) |
| Jun 2013 | - | $7.77 M(+0.3%) |
| Mar 2013 | - | $7.75 M(+16.8%) |
| Dec 2012 | $6.63 M(-45.6%) | $6.63 M(-26.2%) |
| Sep 2012 | - | $8.99 M(-36.0%) |
| Jun 2012 | - | $14.05 M(+8.8%) |
| Mar 2012 | - | $12.90 M(+5.9%) |
| Dec 2011 | $12.19 M | $12.19 M(-14.6%) |
| Sep 2011 | - | $14.27 M(+10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $12.87 M(-12.8%) |
| Mar 2011 | - | $14.77 M(+3.6%) |
| Dec 2010 | $14.26 M(+65.1%) | $14.26 M(-1.6%) |
| Sep 2010 | - | $14.48 M(+79.3%) |
| Jun 2010 | - | $8.08 M(-5.5%) |
| Mar 2010 | - | $8.55 M(-1.0%) |
| Dec 2009 | $8.63 M(+13.4%) | $8.63 M(+8.0%) |
| Sep 2009 | - | $7.99 M(+11.9%) |
| Jun 2009 | - | $7.14 M(+10.3%) |
| Mar 2009 | - | $6.47 M(-15.0%) |
| Dec 2008 | $7.61 M(+269.9%) | $7.61 M(+52.9%) |
| Sep 2008 | - | $4.98 M(+38.7%) |
| Jun 2008 | - | $3.59 M(+50.0%) |
| Mar 2008 | - | $2.39 M(+16.2%) |
| Dec 2007 | $2.06 M(-81.0%) | $2.06 M(-86.5%) |
| Sep 2007 | - | $15.19 M(+11.4%) |
| Jun 2007 | - | $13.63 M(+4.1%) |
| Mar 2007 | - | $13.10 M(+21.1%) |
| Dec 2006 | $10.81 M(+183.5%) | $10.81 M(-31.4%) |
| Sep 2006 | - | $15.77 M(+5.1%) |
| Jun 2006 | - | $15.01 M(+29.9%) |
| Mar 2006 | - | $11.56 M(+203.0%) |
| Dec 2005 | $3.81 M(-63.9%) | $3.81 M(-66.5%) |
| Sep 2005 | - | $11.40 M(-28.3%) |
| Jun 2005 | - | $15.90 M(+8.4%) |
| Mar 2005 | - | $14.67 M(+39.0%) |
| Dec 2004 | $10.55 M(+192.1%) | $10.55 M(-10.2%) |
| Sep 2004 | - | $11.76 M(+232.3%) |
| Jun 2004 | - | $3.54 M(-3.3%) |
| Mar 2004 | - | $3.66 M(+1.2%) |
| Dec 2003 | $3.61 M(-24.2%) | $3.61 M(+42.1%) |
| Sep 2003 | - | $2.54 M(-30.7%) |
| Jun 2003 | - | $3.67 M(-20.1%) |
| Mar 2003 | - | $4.59 M(-3.7%) |
| Dec 2002 | $4.77 M(+97.8%) | $4.77 M(+59.1%) |
| Sep 2002 | - | $3.00 M(+1.2%) |
| Jun 2002 | - | $2.96 M(+6.4%) |
| Mar 2002 | - | $2.78 M(+15.5%) |
| Dec 2001 | $2.41 M(+21.0%) | $2.41 M(+35.1%) |
| Sep 2001 | - | $1.78 M(-6.2%) |
| Jun 2001 | - | $1.90 M(+2.4%) |
| Mar 2001 | - | $1.86 M(-6.8%) |
| Dec 2000 | $1.99 M(+99.2%) | $1.99 M(+20.7%) |
| Sep 2000 | - | $1.65 M(+11.8%) |
| Jun 2000 | - | $1.48 M(-66.5%) |
| Mar 2000 | - | $4.41 M(+340.9%) |
| Dec 1999 | $1.00 M(+100.0%) | $1.00 M(+7.5%) |
| Sep 1999 | - | $930.00 K(+27.7%) |
| Jun 1999 | - | $728.00 K(+11.0%) |
| Mar 1999 | - | $656.00 K |
| Dec 1998 | $500.00 K(-29.2%) | - |
| Dec 1997 | $706.00 K(+4.6%) | - |
| Dec 1996 | $675.00 K(+54.8%) | - |
| Dec 1995 | $436.00 K | - |
FAQ
- What is Abeona Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Abeona Therapeutics?
- What is Abeona Therapeutics annual current liabilities year-on-year change?
- What is Abeona Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly current liabilities year-on-year change?
What is Abeona Therapeutics annual total current liabilities?
The current annual current liabilities of ABEO is $13.42 M
What is the all time high annual current liabilities for Abeona Therapeutics?
Abeona Therapeutics all-time high annual total current liabilities is $41.96 M
What is Abeona Therapeutics annual current liabilities year-on-year change?
Over the past year, ABEO annual total current liabilities has changed by +$5.64 M (+72.54%)
What is Abeona Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ABEO is $18.42 M
What is the all time high quarterly current liabilities for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly total current liabilities is $41.96 M
What is Abeona Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ABEO quarterly total current liabilities has changed by +$5.00 M (+37.25%)